Literature DB >> 26401038

The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.

Jian Guan1, Stephanie M Bywaters2, Sarah A Brendle2, Hyunwook Lee1, Robert E Ashley1, Neil D Christensen2, Susan Hafenstein3.   

Abstract

UNLABELLED: The human papillomavirus (HPV) major structural protein L1 composes capsomers that are linked together through interactions mediated by the L1 C terminus to constitute a T=7 icosahedral capsid. H16.U4 is a type-specific monoclonal antibody recognizing a conformation-dependent neutralizing epitope of HPV thought to include the L1 protein C terminus. The structure of human papillomavirus 16 (HPV16) complexed with H16.U4 fragments of antibody (Fab) was solved by cryo-electron microscopy (cryo-EM) image reconstruction. Atomic structures of virus and Fab were fitted into the corresponding cryo-EM densities to identify the antigenic epitope. The antibody footprint mapped predominately to the L1 C-terminal arm with an additional contact point on the side of the capsomer. This footprint describes an epitope that is presented capsid-wide. However, although the H16.U4 epitope suggests the presence of 360 potential binding sites exposed in the capsid valley between each capsomer, H16.U4 Fab bound only to epitopes located around the icosahedral five-fold vertex of the capsid. Thus, the binding characteristics of H16.U4 defined in this study showed a distinctive selectivity for local conformation-dependent interactions with specific L1 invading arms between five-fold related capsomers. IMPORTANCE: Human papillomavirus 16 (HPV16) is the most prevalent oncogenic genotype in HPV-associated anogenital and oral cancers. Here we use cryo-EM reconstruction techniques to solve the structures of the HPV16 capsid complexes using H16.U4 fragment of antibody (Fab). Different from most other antibodies directed against surface loops, H16.U4 monoclonal antibody is unique in targeting the C-terminal arm of the L1 protein. This monoclonal antibody (MAb) is used throughout the HPV research community in HPV serological and vaccine development and to define mechanisms of HPV uptake. The unique binding mode of H16.U4 defined here shows important conformation-dependent interactions within the HPV16 capsid. By targeting an important structural and conformational epitope, H16.U4 may identify subtle conformational changes in different maturation stages of the HPV capsid and provide a key probe to analyze the mechanisms of HPV uptake during the early stages of virus infection. Our analyses precisely define important conformational epitopes on HPV16 capsids that are key targets for successful HPV prophylactic vaccines.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26401038      PMCID: PMC4645319          DOI: 10.1128/JVI.02020-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Subunit interactions in bovine papillomavirus.

Authors:  Matthias Wolf; Robert L Garcea; Nikolaus Grigorieff; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

2.  Recent trends in type-specific HPV infection rates in the United States.

Authors:  E L Dickson; R I Vogel; X Luo; L S Downs
Journal:  Epidemiol Infect       Date:  2015-04       Impact factor: 2.451

3.  Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine.

Authors:  Michel Deschuyteneer; Abdelatif Elouahabi; Dominique Plainchamp; Michel Plisnier; Dominique Soete; Yvon Corazza; Laurence Lockman; Sandra Giannini; Marguerite Deschamps
Journal:  Hum Vaccin       Date:  2010-05-23

4.  Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Authors:  Katherine M Johnson; Rhonda C Kines; Jeffrey N Roberts; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

5.  Structural comparison of different antibodies interacting with parvovirus capsids.

Authors:  Susan Hafenstein; Valorie D Bowman; Tao Sun; Christian D S Nelson; Laura M Palermo; Paul R Chipman; Anthony J Battisti; Colin R Parrish; Michael G Rossmann
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

6.  Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.

Authors:  Hans-Christoph Selinka; Luise Florin; Hetal D Patel; Kirsten Freitag; Michaela Schmidtke; Vadim A Makarov; Martin Sapp
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

7.  Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58.

Authors:  Sarah A Brendle; Timothy D Culp; Tatevik R Broutian; Neil D Christensen
Journal:  J Gen Virol       Date:  2010-02-24       Impact factor: 3.891

8.  Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16.

Authors:  Michael J Conway; Linda Cruz; Samina Alam; Neil D Christensen; Craig Meyers
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

9.  Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.

Authors:  Qinjian Zhao; Yorgo Modis; Katrina High; Victoria Towne; Yuan Meng; Yang Wang; Jaime Alexandroff; Martha Brown; Bridget Carragher; Clinton S Potter; Dicky Abraham; Dave Wohlpart; Mike Kosinski; Mike W Washabaugh; Robert D Sitrin
Journal:  Virol J       Date:  2012-02-22       Impact factor: 4.099

10.  RELION: implementation of a Bayesian approach to cryo-EM structure determination.

Authors:  Sjors H W Scheres
Journal:  J Struct Biol       Date:  2012-09-19       Impact factor: 2.867

View more
  12 in total

1.  The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction.

Authors:  Zhihai Li; Xiaodong Yan; Hai Yu; Daning Wang; Shuo Song; Yunbing Li; Maozhou He; Qiyang Hong; Qingbing Zheng; Qinjian Zhao; Ying Gu; Jun Zhang; Mandy E W Janssen; Giovanni Cardone; Norman H Olson; Timothy S Baker; Shaowei Li; Ningshao Xia
Journal:  Structure       Date:  2016-06-07       Impact factor: 5.006

2.  Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines.

Authors:  Anna Godi; Alessandra Facchetti; Sara L Bissett; Clementina Cocuzza; Elizabeth Miller; Simon Beddows
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

3.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

4.  Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.

Authors:  Anna Godi; Dolcibella Boampong; Busayo Elegunde; Kavita Panwar; Maxime Fleury; Shaowei Li; Qinjian Zhao; Ningshao Xia; Neil D Christensen; Simon Beddows
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

5.  Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus.

Authors:  Zhihai Li; Daning Wang; Ying Gu; Shuo Song; Maozhou He; Jingjie Shi; Xinlin Liu; Shuangping Wei; Jinjin Li; Hai Yu; Qingbing Zheng; Xiaodong Yan; Timothy S Baker; Jun Zhang; Jason S McLellan; Shaowei Li; Ningshao Xia
Journal:  mBio       Date:  2017-09-26       Impact factor: 7.867

6.  Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.

Authors:  Stephanie M Bywaters; Sarah A Brendle; Kerstin P Tossi; Jennifer Biryukov; Craig Meyers; Neil D Christensen
Journal:  Viruses       Date:  2017-11-10       Impact factor: 5.048

7.  Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles.

Authors:  Daning Wang; Xinlin Liu; Minxi Wei; Ciying Qian; Shuo Song; Jie Chen; Zhiping Wang; Qin Xu; Yurou Yang; Maozhou He; Xin Chi; Shiwen Huang; Tingting Li; Zhibo Kong; Qingbing Zheng; Hai Yu; Yingbin Wang; Qinjian Zhao; Jun Zhang; Ningshao Xia; Ying Gu; Shaowei Li
Journal:  Nat Commun       Date:  2020-06-05       Impact factor: 14.919

8.  Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection.

Authors:  Xinlin Liu; Jie Chen; Zhiping Wang; Daning Wang; Maozhou He; Ciying Qian; Shuo Song; Xin Chi; Zhibo Kong; Qingbing Zheng; Yingbin Wang; Hai Yu; Qinjian Zhao; Jun Zhang; Shaowei Li; Ying Gu; Ningshao Xia
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

9.  High resolution cryo EM analysis of HPV16 identifies minor structural protein L2 and describes capsid flexibility.

Authors:  Daniel J Goetschius; Samantha R Hartmann; Suriyasri Subramanian; Carol M Bator; Neil D Christensen; Susan L Hafenstein
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.379

10.  High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.

Authors:  Jian Guan; Stephanie M Bywaters; Sarah A Brendle; Robert E Ashley; Alexander M Makhov; James F Conway; Neil D Christensen; Susan Hafenstein
Journal:  Viruses       Date:  2017-12-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.